Amazon's AWS to invest $35 billion in Virginia

Motley Fool

Why Evolus Shares Jumped This Week

Shares of Evolus (NASDAQ: EOLS) were up by 27.1% for the week as of Friday afternoon, according to data provided by S&P Global Market Intelligence. The medical aesthetics company specializes in using neurotoxins as aesthetic therapies. The company said in its announcement that it expected fourth-quarter revenue of $43.6 million, up 26% year over year, and full-year revenue of $148.6 million, up 49% over 2021.

Leave a Reply

Your email address will not be published. Required fields are marked *